Intensity-modulated Radiotherapy in the Treatment of Head and Neck Cancer

Clinical Oncology

Volumn 24, Issue 7, 2012, Pages 474-487

  O'Sullivan, B ^a   Rumble, R B ^b   Warde, P ^c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b CANCER CARE ONTARIO   (Canada)

^c Radiation Treatment Program   (Canada)

Author keywords

Best practice; Clinical practice guideline; Evidence based medicine; Head and neck cancer; IMRT; Intensity modulated radiotherapy

Indexed keywords

ADVERSE OUTCOME; ARTICLE; BLINDNESS; BONE NECROSIS; BRACHYTHERAPY; EXTERNAL BEAM RADIOTHERAPY; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT CANCER; SYSTEMATIC REVIEW; TISSUE PRESERVATION; XEROSTOMIA;

HEAD AND NECK NEOPLASMS; HUMANS; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84864778060     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.05.006     Document Type: Article

References (29)

1. Browman G., Levine M., Mohide E., et al. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995, 13(2):502-512.
2. Bauman G., Rumble R.B., Chen J., et al. Intensity-modulated radiotherapy in the Treatment of Prostate Cancer. Clin Oncol 2012, 24. 000-000.
3. Braam P.M., Terhaard C.H.J., Roesink J.M., Raaijmakers C.P.J. Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2006, 66(4):975-980.
4. Fang F.-M., Tsai W.-L., Chen H.-C., et al. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma. Cancer 2007, 109(2):313-321.
5. Graff P., Lapeyre M., Desandes E., et al. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2007, 67(5):1309-1317.
6. Hodge C.W., Bentzen S.M., Wong G., et al. Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison. Int J Radiat Oncol Biol Phys 2007, 69(4):1032-1041.
7. Jabbari S., Kim H.M., Feng M., et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys 2005, 63(3):725-731.
8. Kam M.K.M., Leung S.F., Zee B., et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007, 25(31):4873-4879.
9. Lee N.Y., de Arruda F.F., Puri D.R., et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006, 66(4):966-974.
10. Rades D., Fehlauer F., Wroblesky J., Albers D., Schild S.E., Schmidt R. Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy. Oral Oncol 2007, 43(6):535-543.
11. van Rij C.M., Oughlane-Heemsbergen W.D., Ackerstaff A.H., et al. Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life. Radiat Oncol 2008, 3:41.
12. Yao M., Karnell L.H., Funk G.F., Lu H., Dornfeld K., Buatti J.M. Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2007, 69(5):1354-1360.
13. Chen A.M., Daly M.E., Bucci M.K., et al. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement?. Int J Radiat Oncol Biol Phys 2007, 69(1):141-147.
14. Duthoy W., Boterberg T., Claus F., et al. Postoperative intensity-modulated radiotherapy in sinonasal carcinoma: clinical results in 39 patients. Cancer 2005, 104(1):71-82.
15. Kwong D., McMillan A., Pow E., Sham J. A randomized trial comparing intensity modulated radiotherapy versus 2-dimensional radiotherapy for stage II nasopharyngeal carcinoma. Proc Annu Meet Am Soc Radiat Oncol 2008, 72(1):1.
16. Nutting C., A'Hern R., Rogers M.S., et al. First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005). J Clin Oncol 2009, 27(18 Suppl.):6006.
17. Pow E.H.N., Kwong D.L.W., McMillan A.S., et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006, 66(4):981-991.
18. Lee N., Harris J., Garden A.S., et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009, 27(22):3684-3690.
19. Eisbruch A., Harris J., Garden A.S., et al. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys 2010, 76(5):1333-1338.
20. Madani I., Bonte K., Vakaet L., et al. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys 2009, 73(2):424-432.
21. Sackett D.L., Straus S.E., Richardson W.S., Rosenberg W., Haynes R.B. Evidence-based medicine: how to practice and teach EBM 2000, Churchill Livingstone, Edinburgh. 2nd ed.
22. Ben-David M.A., Diamante M., Radawski J.D., et al. Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions. Int J Radiat Oncol Biol Phys 2007, 68(2):396-402.
23. Studer G., Studer S., Zwahlen R., et al. Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT). Strahlenther Onkol 2006, 182(5):283-288.
24. Lee N., Xia P., Quivey J.M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002, 53(1):12-22.
25. Sultanem K., Shu H.K., Xia P., et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 2000, 48(3):711-722.
26. Waldron J., Tin M.M., Keller A., et al. Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma. Radiother Oncol 2003, 68(2):153-161.
27. Dawson L.A., Anzai Y., Marsh L., et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2000, 46(5):1117-1126.
28. Eisbruch A., Marsh L.H., Dawson L.A., et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004, 59(1):28-42.
29. Cannon D.M., Lee N.Y. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008, 70(3):660-665.